Sleep Deficits and Cannabis Use Behaviors: An Analysis of Shared Genetics Using Linkage Disequilibrium Score Regression and Polygenic Risk Prediction
Evan A. WinigeriD, Jarrod M. EllingsoniD, Claire L. MorrisoniD, Robin P. CorleyiD, Joëlle A. PasmaniD, Tamara L. WalliD, Christian Jean HopferiD, John K. HewittiD
Abstract
Study ObjectivesEstimate the genetic relationship of cannabis use with sleep deficits and eveningness chronotype. MethodsWe used linkage disequilibrium score regression (LDSC) to analyze genetic correlations between sleep deficits and cannabis use behaviors. Secondly, we generated sleep deficit polygenic risk scores (PRSs) and estimated their ability to predict cannabis use behaviors using logistic regression. Summary statistics came from existing genome wide association studies (GWASs) of European ancestry that were focused on sleep duration, insomnia, chronotype, lifetime cannabis use, and cannabis use disorder (CUD). A target sample for PRS prediction consisted of high-risk participants and participants from twin/family community-based studies (n = 796, male = 66%; mean age = 26.81). Target data consisted of self-reported sleep (sleep duration, feeling tired, and taking naps) and cannabis use behaviors (lifetime use, number of lifetime uses, past 180-day use, age of first use, and lifetime CUD symptoms). ResultsSignificant genetic correlation between lifetime cannabis use and eveningness chronotype (rG = 0.24, p < 0.01), as well as between CUD and both short sleep duration (<7 h) (rG = 0.23, p = 0.02) and insomnia (rG = 0.20, p = 0.02). Insomnia PRS predicted earlier age of first cannabis use ({beta} = -0.09, p = 0.02) and increased lifetime CUD symptom count use ({beta} = 0.07, p = 0.03). ConclusionCannabis use is genetically associated with both sleep deficits and an eveningness chronotype, suggesting that there are genes that predispose individuals to both cannabis use and sleep deficits.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 18
- FWCI
- 2.90
- Field percentile
- top 9%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Meta-analysis of Cannabis Use Identifies Shared Genetic Loci with Sleep and Circadian Rhythms
Jesse Tyler Valliere, Satu J. Strausz, … Richa Saxena·medRxiv·Apr 16, 2026
- Investigating the Polygenic Relationship Between Cannabis Use and Schizophrenia in the All of Us Research Program
Isabelle Austin-Zimmerman, Hayley HA Thorpe, … Sandra Sanchez‐Roige·medRxiv·May 20, 2025
- Evidence for genetic correlations and bidirectional, causal effects between smoking and sleep behaviours
Mark Gibson, Marcus Robert Munafo, … Jorien L. Treur·Nicotine & Tobacco ResearchPeer-reviewed·Oct 24, 2018
- The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control analysis from the EUGEI study.
Marta Di Forti, Beatrice Wu-Choi, … EU-GEI WP2 Group·bioRxiv·Nov 16, 2019
- Genome-wide association analysis of lifetime cannabis use (N=184,765) identifies new risk loci, genetic overlap with mental health, and a causal influence of schizophrenia on cannabis use
Joëlle A. Pasman, Karin J. H. Verweij, … Jacqueline M. Vink·bioRxiv·Jan 8, 2018
- Genome-wide association studies of lifetime and frequency cannabis use in 131,895 individuals
Hayley H. A. Thorpe, Pierre Fontanillas, … Sandra Sanchez‐Roige·Molecular PsychiatryPeer-reviewed·Oct 12, 2025